Similar articles

• Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T cells from normal donors and autologous bone marrow transplant candidates.

  Ueda M, Joshi ID, Dan M, Uberti JP, Chou TH, Sensenbrenner LL, Lum LG. Ueda M, et al. Transplantation. 1993 Aug;56(2):351-6. Transplantation. 1993. PMID: 8356589
• Functional and phenotypic characteristics of suppressor T-cells in unresponsive rats pretreated with UV-B irradiated donor lymphocytes combined with peritransplant cyclosporine.

  Oluwole SF, Wasfie T, Fawwaz R, Reemtsma K, Hardy MA. Oluwole SF, et al. Transplant Proc. 1989 Feb;21(1 Pt 1):484-6. Transplant Proc. 1989. PMID: 2523146 No abstract available.
• Recipient-specific donor cytotoxic T lymphocytes enhance engraftment of unrelated, DLA non-identical canine marrow.

  Schwarzinger I, Raff RF, Flowers M, Niederwieser D, Graham T, Shulman H, Appelbaum FR, Schuening F, Storb R. Schwarzinger I, et al. Bone Marrow Transplant. 1994 Mar;13(3):303-9. Bone Marrow Transplant. 1994. PMID: 8199572
• Immunologic monitoring of the renal transplant recipient.

  Suthanthiran M, Garovoy MR. Suthanthiran M, et al. Urol Clin North Am. 1983 May;10(2):315-25. Urol Clin North Am. 1983. PMID: 6222530 Review. No abstract available.
• Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants.

  O'Reilly RJ, Lacerda JF, Lucas KG, Rosenfield NS, Small TN, Papadopoulos EB. O'Reilly RJ, et al. Important Adv Oncol. 1996:149-66. Important Adv Oncol. 1996. PMID: 8791134 Review. No abstract available.